diltiazem has been researched along with monatepil in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoki, K; Karasawa, T; Sugimoto, T | 1 |
| Hosoki, K; Ikeno, A; Karasawa, T; Kato, H; Kurokawa, M; Masuda, Y; Minato, H; Yamada, T; Zushi, K | 1 |
| Fukuya, F; Hosoki, K; Ikeno, A; Karasawa, T; Minato, H; Nose, I; Takeyama, K | 1 |
| Hosoki, K; Karasawa, T; Kikuta, C; Yamamoto, T | 1 |
| Hatano, N; Honda, Y; Hosoki, K; Karasawa, T; Kataoka, T; Masuda, Y; Nose, I; Yamada, T | 1 |
| Fukuya, F; Honda, Y; Hosoki, K; Ikeno, A; Karasawa, T; Kataoka, T; Minato, H; Nose, I; Takeyama, K; Yamada, T | 1 |
| Hayashi, K; Kajiyama, G; Kuga, Y; Kuwashima, J; Nomura, K; Nomura, S; Okura, Y; Shingu, T; Tanaka, K; Yasunobu, Y | 1 |
7 other study(ies) available for diltiazem and monatepil
| Article | Year |
|---|---|
Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Decerebrate State; Dibenzothiepins; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Hypotension; Injections, Intravenous; Piperazines; Prazosin; Rats; Rats, Wistar | 1995 |
Inhibitory effect of the new calcium antagonist AJ-2615 on progression of atherosclerosis in cholesterol-fed rabbits.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Cholesterol, Dietary; Dibenzothiepins; Diltiazem; Male; Phospholipids; Piperazines; Prazosin; Rabbits; Triglycerides | 1993 |
Antihypertensive effects of AJ-2615, a new calcium antagonist with alpha 1-adrenergic blocking activity in experimental hypertensive animals.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Desoxycorticosterone; Dibenzothiepins; Diltiazem; Dogs; Female; Heart Rate; Hypertension; Hypertension, Renovascular; Male; Nicardipine; Nifedipine; Piperazines; Rats; Rats, Inbred SHR; Rats, Wistar | 1993 |
Preventive effect of monatepil on thromboxane A2 agonist-induced myocardial ischemia in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Calcium Channel Blockers; Dibenzothiepins; Diltiazem; Electrocardiography; Heart Rate; Male; Myocardial Ischemia; Myocardium; Oxygen Consumption; Piperazines; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dibenzothiepins; Diltiazem; Dogs; Electrocardiography; Female; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Oxygen Consumption; Papillary Muscles; Piperazines; Rabbits; Vascular Resistance | 1993 |
In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
Topics: Anesthesia; Animals; Blood Pressure; Bundle of His; Calcium Channel Blockers; Dibenzothiepins; Diltiazem; Dogs; Electrocardiography; Female; Heart; Heart Conduction System; Heart Rate; Hypertension; In Vitro Techniques; Male; Nifedipine; Piperazines; Rabbits; Verapamil | 1993 |
Inhibition of lipid hydroperoxidation of low density lipoprotein by the Ca(2+)-channel and alpha 1-adrenoceptor antagonist monatepil maleate.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anticholesteremic Agents; Calcium Channel Blockers; Copper; Copper Sulfate; Depression, Chemical; Dibenzothiepins; Diltiazem; Humans; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, LDL; Piperazines; Prazosin; Probucol | 1996 |